Hudson Square Pharma Private Limited
About Hudson Square Pharma Private Limited
Data last updated:
Hudson Square Pharma Private Limited is a private limited company based in Patiala, Punjab, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 08 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U85100PB2021PTC054184.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Neeraj Gupta and Bharat Sandhal.
Its last annual general meeting (AGM) was held on 22 December 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at St. No. 1 Vikas Nagar Back Side Power Grid Sector – 1C Mandi Gobindgarh, Patiala, Punjab, India – 147301.
As per the financials filed for FY 2023, the company reported a revenue of ₹35.54 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹7.17 Lakh (net margin -20.2%) and EBITDA of -₹8.17 Lakh (EBITDA margin -23%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSt. No. 1 Vikas Nagar Back Side Power Grid Sector – 1C Mandi Gobindgarh, Patiala, Punjab, India – 147301
- IndustryHealthcare, Human Health Activities
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Hudson Square Pharma Private Limited
The main business activity of Hudson Square Pharma is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Hudson Square Pharma Private Limited FY 2023 filings available
Hudson Square Pharma Private Limited reported revenue of ₹35.54 Lakh (up 813% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR) of Hudson Square Pharma Private Limited
Revenue rose 813% in the latest year. EBITDA fell 6% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Hudson Square Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | -₹8.17 Lakh | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹7.17 Lakh | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Hudson Square Pharma Private Limited
| Metrics | FY 2022-23 | FY 2021-22 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -23% | •••• |
| Net Profit Margin | -20.2% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Hudson Square Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Hudson Square Pharma Private Limited
Hudson Square Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Jagware Trading India Private Limited | ₹35.55 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Lucknow, Uttar Pradesh, India |
| Soielife Creations Private Limited | ₹35.55 Lakh (FY 2025) | •••• | •••• | 36.0% | •••• | Varanasi, Uttar Pradesh, India |
| Adisa Trading Private Limited | ₹35.55 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Bhubaneswar, Odisha, India |
| Ojass Healthcare Products (OPC) Private Limited | ₹35.54 Lakh (FY 2022) | •••• | •••• | 29.0% | •••• | Bareilly, Uttar Pradesh, India |
| Bhoomi Shakti Krishi Producer Company Limited | ₹35.54 Lakh (FY 2025) | •••• | •••• | 269.0% | •••• | Umerth, Madhya Pradesh, India |
| Hudson Square Pharma Private Limited this company | ₹35.54 Lakh (FY 2023) | •••• | •••• | 813.0% | •••• | Patiala, Punjab, India |
| Jalees Tanners Private Limited | ₹35.54 Lakh (FY 2025) | •••• | •••• | -34.0% | •••• | Kanpur, Uttar Pradesh, India |
| Sirmaur Consumer Products Private Limited | ₹35.53 Lakh (FY 2024) | •••• | •••• | •••• | Bareilly, Uttar Pradesh, India | |
| Vanaspati Creation Private Limited | ₹35.53 Lakh (FY 2020) | •••• | •••• | -62.0% | •••• | Surat, Gujarat, India |
| Falgun Merchants Private Limited | ₹35.53 Lakh (FY 2025) | •••• | •••• | -3.0% | •••• | Kolkata, West Bengal, India |
| Kitchen Boost Private Limited | ₹35.53 Lakh (FY 2024) | •••• | •••• | 64.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Hudson Square Pharma by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Hudson Square Pharma Private Limited
Hudson Square Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neeraj Gupta | Director | 08 Sep 2021 | 5 Years 1 Months | Current |
| Bharat Sandhal | Director | 08 Sep 2021 | 5 Years 1 Months | Current |
Charges & Borrowings of Hudson Square Pharma Private Limited
Hudson Square Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Hudson Square Pharma Private Limited
Employment history and EPFO contributions of people linked to Hudson Square Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Hudson Square Pharma Private Limited
Hudson Square Pharma Private Limited has 4 board changes on record since 2021: 2 appointments and 2 cessations. The latest: Amit Sandhal ceased to be Director on 01 Jun 2023.
Credit Ratings, Litigation & Regulatory Alerts for Hudson Square Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Hudson Square Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Hudson Square Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Hudson Square Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Hudson Square Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hudson Square Pharma Private Limited
Hudson Square Pharma is an active private limited company based in Patiala, Punjab, India. The company works in human health activities, within the healthcare industry. It was incorporated on 08 September 2021 (5+ years old) and is registered under CIN U85100PB2021PTC054184.
Hudson Square Pharma reported revenue of ₹35.54 Lakh for FY 2023 (up 813% YoY).
Hudson Square Pharma has 2 current directors:
- Neeraj Gupta - Director
- Bharat Sandhal - Director
Hudson Square Pharma reported a net loss of ₹7.17 Lakh (net margin -20.2%) and EBITDA of -₹8.17 Lakh (EBITDA margin -23%) for FY 2023, as per its filed financial statements.
The CIN (Corporate Identification Number) of Hudson Square Pharma is U85100PB2021PTC054184. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hudson Square Pharma was incorporated on 08 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Hudson Square Pharma by revenue are Jagware Trading India Private Limited, Soielife Creations Private Limited, Adisa Trading Private Limited, Ojass Healthcare Products (OPC) Private Limited, Bhoomi Shakti Krishi Producer Company Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Amit Sandhal ceased to be Director on 01 Jun 2023. Harpreet Singh Jolly ceased to be Director on 23 Mar 2023. Bharat Sandhal was appointed as Director on 08 Sep 2021. Hudson Square Pharma has 4 board changes on record in total.
The registered office of Hudson Square Pharma is at St. No. 1 Vikas Nagar Back Side Power Grid Sector – 1C Mandi Gobindgarh, Patiala, Punjab, India – 147301.
Hudson Square Pharma has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh.
Hudson Square Pharma operates in the healthcare industry, in the human health activities segment.